Literature DB >> 33898566

Progress in TNM staging of pancreatic neuroendocrine tumors.

Taymeyah Al-Toubah1, Jonathan Strosberg1.   

Abstract

Entities:  

Year:  2021        PMID： 33898566      PMCID： PMC8050571          DOI： 10.21037/hbsn-20-772

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  What's in a Name? Steady Progress in Staging Pancreatic Neuroendocrine Tumors.

Authors:  Daniel M Halperin; James C Yao; Arvind Dasari
Journal:  J Clin Oncol       Date:  2016-11-28       Impact factor: 44.544

2.  Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.

Authors:  Jonathan R Strosberg; Asima Cheema; Jill Weber; Gang Han; Domenico Coppola; Larry K Kvols
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

3.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

Review 4.  Consensus on biomarkers for neuroendocrine tumour disease.

Authors:  Kjell Oberg; Irvin M Modlin; Wouter De Herder; Marianne Pavel; David Klimstra; Andrea Frilling; David C Metz; Anthony Heaney; Dik Kwekkeboom; Jonathan Strosberg; Timothy Meyer; Steven F Moss; Kay Washington; Edward Wolin; Eric Liu; James Goldenring
Journal:  Lancet Oncol       Date:  2015-09       Impact factor: 41.316

5.  Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.

Authors:  Guopei Luo; Ammar Javed; Jonathan R Strosberg; Kaizhou Jin; Yu Zhang; Chen Liu; Jin Xu; Kevin Soares; Matthew J Weiss; Lei Zheng; Christopher L Wolfgang; Mauro Cives; Joyce Wong; Wei Wang; Jian Sun; Chenghao Shao; Wei Wang; Huangying Tan; Jie Li; Quanxing Ni; Lin Shen; Minhu Chen; Jin He; Jie Chen; Xianjun Yu
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

6.  Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

Authors:  Karl Y Bilimoria; David J Bentrem; Ryan P Merkow; James S Tomlinson; Andrew K Stewart; Clifford Y Ko; Mark S Talamonti
Journal:  J Am Coll Surg       Date:  2007-08-03       Impact factor: 6.113

7.  A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.

Authors:  Benjamin D Powers; Luke D Rothermel; Jason B Fleming; Jonathan R Strosberg; Daniel A Anaya
Journal:  J Gastrointest Surg       Date:  2019-11-21       Impact factor: 3.452

8.  Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.

Authors:  Xu-Feng Zhang; Feng Xue; Zheng Wu; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio Rocha; Zaheer Kanji; Sharon Weber; Alexander Fisher; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; Cliff Cho; Megan Beems; Yi Lyu; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg       Date:  2020-06-03       Impact factor: 12.969

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Mauro Cives; Stefano Partelli; Raffaele Palmirotta; Domenica Lovero; Barbara Mandriani; Davide Quaresmini; Eleonora Pelle'; Valentina Andreasi; Paola Castelli; Jonathan Strosberg; Giuseppe Zamboni; Massimo Falconi; Franco Silvestris
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.